FORM DEF 14A

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

August 26, 2016

Period of Report

October 20, 2016

Accession Number

0001437749-16-038093

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →